CHRO vs REGN: Which Stock is Better?
Side-by-side comparison of Chromocell Therapeutics Corporation and Regeneron Pharmaceuticals Inc in 2026
CHRO
Chromocell Therapeutics Corporation
—
REGN
Regeneron Pharmaceuticals Inc
$635.45
Key Metrics Comparison
| Metric | CHRO | REGN | Winner |
|---|---|---|---|
| Market Cap | $8.90M | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze CHRO
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHRO or REGN a better investment?
Comparing CHRO and REGN: Chromocell Therapeutics Corporation has a market cap of $8.90M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHRO and REGN?
CHRO (Chromocell Therapeutics Corporation) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHRO or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CHRO or REGN?
Both CHRO and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: CHRO or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: CHRO or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $8.90M for CHRO.
Should I buy CHRO or REGN in 2026?
Both CHRO and REGN have investment merit. CHRO trades at $N/A while REGN trades at $635.45. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHRO and REGN stock?
Key differences: Market Cap ($8.90M vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy CHRO or REGN in 2026?
The choice between CHRO and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CHRO and REGN?
CHRO (Chromocell Therapeutics Corporation) has a market cap of $8.90M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.